Maggie D. Flores, P.C.
Overview
Maggie Flores is a corporate partner in the New York office of Kirkland & Ellis LLP. Maggie represents an extensive roster of clients ranging from blue chip public companies to leading private equity sponsors to prominent private companies who tap her for their most complex and transformative transactions, including structuring and negotiating domestic and international mergers, acquisitions and divestitures, leveraged buyouts, carve-outs, de-SPAC transactions, capital markets offerings, and other recapitalizations, restructurings and strategic transactions. She also counsels clients on a range of general corporate and securities law matters, including corporate governance and fiduciary duties.
Maggie was recognized in Bloomberg’s “They’ve Got Next” series in 2024 and as a “Rising Star” by The New York Law Journal as part of its 2024 New York Legal Awards. Maggie was also named one of “New York’s Notable Women in Law” by Crain’s New York Business in 2023 and was selected as one of the “Top Women in Dealmaking” by The Deal in 2022. Maggie is a regular speaker at Practising Law Institute (PLI) events, including co-chairing PLI’s M&A Conference from 2022 to 2024 and its Securities Law Conference in 2024.
Experience
Representative Matters
Public Company Representations
- AbbVie in several transactions, including:
- $63 billion acquisition of Allergan and related $30 billion offering of senior notes to fund the acquisition; the offerings represent the largest corporate bond sale of 2019 and the fourth-largest in history
- exchange offers and consent solicitations for ~$22 billion of Allergan debt in connection with AbbVie’s acquisition of Allergan
- acquisition of Soliton for ~$550 million
- Caesars Entertainment in the pending $500 million sale of its World Series of Poker brand to NSUS Group
- Palo Alto Networks in its $500 million acquisition of IBM’s QRadar Software as a Service business, and its strategic partnership with IBM to deliver AI-powered security outcomes to customers
- Carlisle Companies in the $2.025 billion sale of Carlisle Interconnect Technologies to Amphenol Corporation
- Bristol Myers Squibb in its acquisition of MyoKardia (NASDAQ: MYOK) for approximately $13.1 billion
- Owens & Minor in its $1.6 billion acquisition of Apria (NASDAQ: APR)
- KRAFTON in its $750 million acquisition of Unknown Worlds Entertainment
- Avaya Holdings in its $500 million strategic partnership with RingCentral
- Tenneco in its $5.4 billion acquisition of Federal Mogul
- R1 RCM in several transactions including its strategic investments by Towerbrook and Intermountain Health and in its $460 million acquisition of Intermedix
- Ingevity Corp. in its $315 million acquisition of Georgia-Pacific's pine chemical business
- Epiq Systems in its $1 billion sale to OMERS Private Equity
- Deere & Co. in several transactions, including:
- its $5.2 billion acquisition of The Wirtgen Group
- in numerous investment-grade offerings totaling over $10.3 billion
- Norwegian Cruise Line Holdings in its PIPE investment from L Catterton as part of Norwegian’s multi-tranche financing for aggregate proceeds of approximately $2.4 billion
- United Airlines in connection with the Payroll Support Program under the CARES Act
- TerraForm Global in its $810 million high-yield offering
- Solera Holdings in its $400 million high-yield offering
- SunEdison Semiconductor in connection with its $107.6 million initial public offering and $227.9 million follow-on offering
- Zebra Technologies in its acquisition of Motorola Solutions and related $1.05 billion high-yield offering to fund the acquisition and its acquisition of Xplore Technologies
- CDW Corporation in its $454.5 million initial public offering, subsequent follow-on offerings totaling approximately $1.4 billion and $600 million high-yield offering
- GSE Holding in its $72.5 million initial public offering
Private Equity and other Private Company Representations
- TPG in several transactions, including:
- its majority investment in Surescripts
- its sale of PS to Groupe ADP
- the sale of its portfolio company CLEAResult to Kohlberg & Company
- its acquisition of Troon
- the sale of its portfolio company Llamasoft to Coupa Software (NASDAQ: COUP) for approximately $1.5 billion
- its investment of LifeStance Health
- the sale of its portfolio company Transplace to Uber (NYSE: UBER) for approximately $2.25 billion
- Patient Square Capital in multiple transactions, including:
- the consortium acquisition of Syneos Health for approximately $7.1 billion
- its $890 million acquisition of Radius Health
- Centerbridge Partners in several transactions, including:
- its pending acquisition of Precinmac
- its acquisition of MacLean Power Systems
- its $1.6 billion acquisition alongside Bridgeport Partners of Computer Services Inc.
- its majority investment in Syncapay for the acquisition of North Lane Technologies (formerly Wirecard North America) and combination with daVinci Payments
- its acquisition of American Bath Group
- the formation and launch of Martello Re and related reinsurance and asset management arrangements
- its investment in Heartland Food Products Group
- Cressey & Company in multiple transactions, including:
- the acquisition of HealthDrive
- the acquisition alongside Health Enterprise Partners of The InterMed Group
- HHAeXchange in its investment from Hg
- the acquisition of HHAeXchange
- the acquisition of Elite Dental
- Apax Partners in its $1.75 billion take-private acquisition of Thoughtworks
- Weeks Marine, Inc., in its sale to Kiewit Corporation
- Paine Schwartz Partners in mutltiple transactions, including:
- its acquisition of AgroFresh Solutions
- its $150 million PIPE investment in AgroFresh Solutions
- Starwood Capital Group on its acquisition of Extended Stay America in joint venture with Blackstone for approximately $6 billion
- iNRCORE LLC, a portfolio company of The Jordan Company, in its acquisition of Gowanda Components Group
- Amer Sports and its investor consortium in Precor’s sale to Peloton for approximately $420 million
- Brookfield on its acquisition of the Everise platform from Everstone
- Rush Street Interactive in its $1.7 billion business combination with dMY Technology Group
- Harvest Partners in its acquisition of Service Express
- Wellspring Capital Partners in its acquisitions of Steele Solutions, Inc. and Milan Supply Chain Solutions
- Greenbriar on its acquisition of Arotech Corporation (NASDAQGM: ARTX)
- Thoma Bravo in numerous transactions, including:
- the $1.6 billion acquisition of Barracuda Networks (NASDAQ: CUDA)
- the acquisition of Quorum Software, as well as Quorum Software’s acquisitions of Coastal Flow and Archeio Technologies
- the acquisitions of Aucerna, Nintex Global, Riskonnect and Planview
- the $240 million initial public offering of SailPoint Technologies Holdings, Inc. (NASDAQ: SAIL), and in several subsequent secondary offerings
- the acquisition of TRADER Corporation for approximately C$1.575 billion
- the acquisition of Riverbed Technology and the related $525 million high-yield bond offering to fund the acquisition
- Linden Capital Partners in numerous transactions, including:
- the acquisition of Biospecimen Holdings, a portfolio company of Arsenal Capital Partners
- the acquisition of Hydrafacial and the subsequent $1.1 billion combination of Hydrafacial with Vesper Healthcare Acquisition Corp.
- the acquisition and subsequent sale of Z-Medica to Teleflex Incorporated (NYSE: TFX)
- the acquisition of Chesapeake IRB, its combination with Shulman IRB to become Advarra and Advarra’s subsequent $1.28 billion sale to Genstar
- the acquisition of Young Innovations, several add-on acquisitions including the acquisition of Oral-B professional care products from Procter & Gamble, and the subsequent sale of Young Innovations to The Jordan Company
- the sale of CORPAK MedSystems to Halyard Health, Inc. (NYSE: HYH)
- the acquisitions of Spear Education, Virtus Pharmaceutical and Sage Dental
- the sales of Behavioral Centers of America, Hycor Biomedical and Drayer Physical Therapy
- Reverence Capital Partners in its acquisition of Advisor Group, Inc.
- Arsenal Capital-backed CPS Performance Materials Group in its acquisition of GEO Specialty Chemicals
- High Plaines Gaming, an affiliate of Rush Street Gaming , in connection with Churchill Down’s acquisition of an ownership stake in Rivers Casino Des Plaines
- Victory Park Capital in its PIPE investment in Rimini Street, Inc. (NASDAQ: RMNI) and the sale of a minority stake to Pacific Current Group
- MAI Holdings in its $135 million high-yield offering
- New Harbor Capital in its acquisitions of FYZICAL and Certica Solutions
- GCA Services Group in its $1.25 billion sale to ABM (NYSE: ABM)
- CHS Capital in the sale of TricorBraun Holdings to AEA Investors and the acquisition and subsequent sale of Royall & Company to the Advisory Board Company for $850 million
- Navistar International in its $300 million high-yield offering
- Arlon Group in its acquisition of the Coastal Companies
- Madison Dearborn Partners in its acquisition of a majority interest in Walgreens Infusion Services
- Harren Equity Partners in the acquisition of Virginia Tile Company and the sale of Huskie Tools
- Blue Point Capital in the sale of Callison Architecture to Arcadis NV
- Clear Channel Communications in its $575 million high-yield offering and $1.2 billion investment-grade offering
- Accel-KKR in Kana Software’s acquisition of Ciboodle and Kana Software’s subsequent sale to Verint Systems (NASDAQ:VRNT)
- Parthenon Capital in its acquisition of Merchant Warehouse and in several add-on acquisitions for Altegra Health, a Parthenon Capital portfolio company
- Olympus Partners in its $190 million high-yield offering to fund the acquisition of NPC International
- Ally Bank and Ally Financial in two asset-backed notes offerings totaling over $2 billion
More
Thought Leadership
Speaking Engagements
Co-Chair and Speaker, “Current Landscape of the M&A Market,” Practising Law Institute, September 2024
Moderator, “Maximizing Impact: How GCs Can Partner with CEOs and Boards for Success,” The Fourth Effect, June 2024
Co-Chair and Speaker, “55th Annual Institute on Securities Regulation,” Practising Law Institute, June 2024
Moderator, “Middle Market Buyouts,” Wharton Private Equity & Venture Capital Conference, March 2024
Speaker, "State of Private Equity Panel," Wharton Women in Investing Conference, February 2023
Speaker, “What Keeps You Up At Night? The Role of a Public Company GC Today,” The Fourth Effect, December 2021
Speaker, “Dissecting the SPAC Mania Part 1: Navigating the Legal Landscape,” and “Part 2: Tips for Surviving a de-SPAC Transaction,” The Fourth Floor, June–July 2021
Speaker, “Proxy Solicitations in the Age of Corporate Activism,” Understanding the Securities Laws, Practising Law Institute, 2018-2022
Recognition
Recognized as a “Rising Star” by the New York Law Journal, 2024
Recognized in Bloomberg’s “They’ve Got Next” Series, 2024
Recognized as a “Notable Practitioner” for Corporate and M&A and Private Equity by IFLR1000, 2021–2024
Recognized as one of “New York’s Notable Women in Law” by Crain’s New York Business, 2023
Recognized as one of the “Top Women in Dealmaking” by The Deal, 2022
Memberships & Affiliations
Credentials
Admissions & Qualifications
- New York
- Illinois
Education
- Indiana University Maurer School of LawJ.D.summa cum laude
First in Class
Order of the Coif
Scribe Award for Excellence in Legal Writing
Articles Editor, Indiana Law Journal
- Princeton UniversityA.B., EnglishCertificate in Finance